| Name | Title | Contact Details |
|---|
Natural molecules or derivatives make up more than half of the current drugs on the market with applications to nearly every disease known to humans. Salicylic acid, morphine, cannabinoids and insulin are a few examples. Our specialty is in producing these, and new targets, using a fast and scalable platform based on engineered microbes.
NeuroVasc Technologies is a developer of mechanical thrombectomy solutions for revascularization of the brain.
Biocomputing Platforms is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Endeavor is a clinical-stage company developing a best-in-class Hedgehog inhibitor for Idiopathic Pulmonary Fibrosis.
FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered `undruggable`.